Nykredit A/S’s Medline Inc MDLN Stock Holding History

Nykredit A/S’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.42M	Buy	+36,116	New	+$1.46M	﹤0.01%	616

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $2.8B AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

ECU

Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Nykredit A/S's MDLN Position: Q2 2026 in Review

Nykredit A/S opened a new position in Medline Inc (MDLN) in Q2 2026: 36,116 shares worth $1.42M. The stake represents ﹤0.01% of the portfolio and ranks #616 among its holdings.

283 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

Nykredit A/S held 36,116 shares of Medline Inc worth $1.42M as of Q2 2026.
Medline Inc was a new Nykredit A/S position in Q2 2026.
Medline Inc made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #616 holding.
283 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.